Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tissue-resident memory CD8+ T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells
Evelyn Menares, Felipe Gálvez‐Cancino, Pablo Cáceres-Morgado, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 188

Showing 1-25 of 188 citing articles:

Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
Suchit Jhunjhunwala, Christian Hammer, Lélia Delamarre
Nature reviews. Cancer (2021) Vol. 21, Iss. 5, pp. 298-312
Closed Access | Times Cited: 983
Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy
Chirag Krishna, Renzo G. DiNatale, Fengshen Kuo, et al.
Cancer Cell (2021) Vol. 39, Iss. 5, pp. 662-677.e6
Open Access | Times Cited: 279
An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer
Paula Voabil, Marjolein de Bruijn, Lisanne M. Roelofsen, et al.
Nature Medicine (2021) Vol. 27, Iss. 7, pp. 1250-1261
Closed Access | Times Cited: 242
Tissue-resident memory T cells in breast cancer control and immunotherapy responses
Ann Byrne, Peter Savas, Sneha Sant, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 6, pp. 341-348
Closed Access | Times Cited: 236
Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy
Amrita Basu, Ganesan Ramamoorthi, Gabriella Albert, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 225
Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer
Zebo Jiang, Wenjun Wang, Cong Xu, et al.
Cancer Letters (2021) Vol. 515, pp. 36-48
Closed Access | Times Cited: 158
Tissue-resident memory T cells in tumor immunity and immunotherapy
Karolina Okła, Donna L. Färber, Weiping Zou
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 4
Open Access | Times Cited: 147
Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells
Carmen M. Anadon, Xiaoqing Yu, Kay Hänggi, et al.
Cancer Cell (2022) Vol. 40, Iss. 5, pp. 545-557.e13
Open Access | Times Cited: 111
Characterisation and induction of tissue-resident gamma delta T-cells to target hepatocellular carcinoma
Nekisa Zakeri, Andrew Hall, Leo Swadling, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 87
Tumor–Antigen Activated Dendritic Cell Membrane-Coated Biomimetic Nanoparticles with Orchestrating Immune Responses Promote Therapeutic Efficacy against Glioma
Xiaoyue Ma, Lei Kuang, Ying Yin, et al.
ACS Nano (2023) Vol. 17, Iss. 3, pp. 2341-2355
Closed Access | Times Cited: 85
Hallmarks of Resistance to Immune-Checkpoint Inhibitors
Maria Karasarides, Alexandria P. Cogdill, Paul B. Robbins, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 4, pp. 372-383
Open Access | Times Cited: 77
Stem-like exhausted and memory CD8+ T cells in cancer
Thomas Gebhardt, Simone L. Park, Ian A. Parish
Nature reviews. Cancer (2023) Vol. 23, Iss. 11, pp. 780-798
Closed Access | Times Cited: 73
Lipid-associated macrophages transition to an inflammatory state in human atherosclerosis, increasing the risk of cerebrovascular complications
Lea Dib, Lada A. Koneva, Andreas Edsfeldt, et al.
Nature Cardiovascular Research (2023) Vol. 2, Iss. 7, pp. 656-672
Open Access | Times Cited: 50
Early immune pressure initiated by tissue-resident memory T cells sculpts tumor evolution in non-small cell lung cancer
Clare E. Weeden, Velimir Gayevskiy, Claire Marceaux, et al.
Cancer Cell (2023) Vol. 41, Iss. 5, pp. 837-852.e6
Open Access | Times Cited: 45
PD-1 defines a distinct, functional, tissue-adapted state in Vδ1+ T cells with implications for cancer immunotherapy
Daniel Davies, Shraddha Kamdar, Richard Woolf, et al.
Nature Cancer (2024)
Open Access | Times Cited: 20
Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization
Zhiguang Chang, Xuan Guo, Xuefei Li, et al.
Cell (2025)
Closed Access | Times Cited: 2
Memory CD8+ T cell responses to cancer
Jichang Han, Nikhil Khatwani, Tyler G. Searles, et al.
Seminars in Immunology (2020) Vol. 49, pp. 101435-101435
Open Access | Times Cited: 135
Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types
Jasneet Kaur Khalsa, Nina Cheng, Joshua Keegan, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 120
The Role of Antigen Spreading in the Efficacy of Immunotherapies
Peter Brossart
Clinical Cancer Research (2020) Vol. 26, Iss. 17, pp. 4442-4447
Closed Access | Times Cited: 106
Resident and circulating memory T cells persist for years in melanoma patients with durable responses to immunotherapy
Jichang Han, Yanding Zhao, Keisuke Shirai, et al.
Nature Cancer (2021) Vol. 2, Iss. 3, pp. 300-311
Open Access | Times Cited: 101
Single-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichment
Kristen E. Pauken, Osmaan Shahid, Kaitlyn A. Lagattuta, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 4
Open Access | Times Cited: 97
Evodiamine suppresses non-small cell lung cancer by elevating CD8+ T cells and downregulating the MUC1-C/PD-L1 axis
Zebo Jiang, Jumin Huang, Ya‐Jia Xie, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 94
Anti-tumor immunity in mismatch repair-deficient colorectal cancers requires type I IFN–driven CCL5 and CXCL10
Courtney Mowat, Shayla R. Mosley, Afshin Namdar, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 9
Open Access | Times Cited: 87
Daily caloric restriction limits tumor growth more effectively than caloric cycling regardless of dietary composition
Laura C. D. Pomatto-Watson, Monica Bodogai, Oye Bosompra, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 84
Overcoming the challenges associated with CD3+ T-cell redirection in cancer
Ajit Kumar Singh, Sundee Dees, Iqbal S. Grewal
British Journal of Cancer (2021) Vol. 124, Iss. 6, pp. 1037-1048
Open Access | Times Cited: 80
Page 1 - Next Page

Scroll to top